48 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures purchased 237,500 shares of Wilhelmina.
Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $40
Morgan Stanley maintains SI-BONE (NASDAQ:SIBN) with a Overweight and lowers the price target from $41 to $40.
Needham Maintains Buy on SI-BONE, Lowers Price Target to $37
Needham analyst David Saxon maintains SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $42 to $37.
SI-BONE: Q2 Earnings Insights
Shares of SI-BONE (NASDAQ:SIBN) were flat in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 4.55% over the past year to ($0.42), which missed the estimate of ($0.39).
Earnings Scheduled For August 2, 2021
Companies Reporting Before The Bell
• HSBC Holdings (NYSE:HSBC) is estimated to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.
SI-BONE’s Sacroiliac Joint Implant Show Accelerated Fusion, Reduction In Opioid Use
SI-BONE Inc (NASDAQ: SIBN) has announced the publication of 2-year results from the SALLY study of the iFuse-3D Implant System. Clinical results at 24…
The Daily Biotech Pulse: Priority Review For Amgen’s Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)